Northeastern University Graduate Admissions’ Post

Within Europe, our pharmaceutical and biotech expertise is excellent, but with an aging population, stricter environmental laws and a global supply chain, there is clearly a need for a different perspective on how manufacturing is done. And this acceleration needs to happen quickly. Our latest blogpost summarizes the new EU pharmaceutical strategy and the challenges that lie ahead for the pharmaceutical sector. What will you as organization do to not only survive, but to thrive? Read our blog here: Europe draws lessons from Covid crisis regarding its pharmaceutical industry supply chains https://lnkd.in/e6P3VxTz

Another to the List , Completed Drug Commercialization Course Authorized by University of California San Diego. Equipped with invaluable knowledge on regulatory affairs, market analysis, and product launch strategies. Ready to apply learnings to drive innovation in the pharmaceutical industry. #DrugCommercialization #MarketAnalysis #DrugLaunch #RegulatoryAffairs #ProductCommercializationStrategy #PharmaBusiness

Are you an emerging leader #Skyhealthacademy #Pharmaceuticals #Medicalaffairs #pharma #Education in Medical Affairs in the pharmaceutical industry? Check this blog post https://buff.ly/4b5EKky Our "Field Medical Leadership" course is tailor-made for you, offering the critical resources needed to shine in leadership and managerial positions. Dive into our no-cost class and start your journey to excellence 👉 https://buff.ly/42GEjK8

👉 Want to find out what strategy development is and why it's important for the Medical Affairs function? Our training course on Medical Affairs in Practise is designed for Medical Affairs professionals from pharma and biotech companies to learn together. All topics covered in this course have been specifically chosen based on recommendations from senior medics with extensive pharmaceutical industry experience. 📝 Our last session for 2023 is available to book over on the PM Society website https://lnkd.in/eSx8eDY5 #medicaleducation #medicalaffairs #medicaltraining #pharmaceuticals #biotech #biotechnology #training #healthcaretraining

In the pharmaceutical industry, different departments like R&D, Supply Chain, and Finance each have their own ways of defining and describing products based on their specific needs and data methods. This can create difficulties in aligning product information because each department uses its own separate and incompatible systems. 📅 This Thursday, June 27, we are hosting a webinar to discuss how Identification of Medicinal Products standards (#IDMP) help organize product master data for R&D and Supply Chain management. These standards add value and speed up business processes by offering the first internationally standardized model for medicinal products that can be used across various departments. Speakers joining the discussion include: 👉 Jean-Gonzague FONTAINE, Product and Susbtance Master Data Lead, GSK 👉 Malin Fladvad Portfolio Officer, Uppsala Monitoring Centre 👉 Laurent Lefebvre, Regulatory CMC Director, Novartis Registrations are still open - make sure to save your spot 📌 https://lnkd.in/gurgtstf

What is strategy development and why is it important for the Medical Affairs function? Find out in our Medical Affairs in Practise training course. Designed for Medical Affairs professionals from pharma and biotech companies to learn together, the topics in this course have been specifically chosen based on recommendations from senior medics with extensive pharmaceutical industry experience. Secure your space on our next session from 9am to 11am on the 23rd, 25th, 27th, 31st of October & 2nd of November https://lnkd.in/eSx8eDY5 #medicaleducation #medicalaffairs #medicaltraining #pharmaceuticals #biotech #biotechnology #training #healthcaretraining

I’m happy to share that I’ve obtained a new certification: Drug Development Product Management Specialization from University of California San Diego! Coursera. Thanks to this specialization, I was able to obtain a comprehensive understanding of the entire drug discovery and development process. In the first course, I acquired knowledge about the procedure that scientists use to select a target for drug discovery and then file an Investigational New Drug Application (IND). In the second course, I acquired information about the complicated procedures involved in drug development, including submitting a New Drug Application (NDA) and completing Phase 0 through Phase 3 clinical trials. Ultimately, course three made me aware of the challenges associated with launching new pharmaceutical goods and ensuring the success of revenue estimates. #DrugDiscovery #DrugDevelopment #ProductManagement #Regulatory #Coursera

I personally wish I knew more about industry options in the pharmaceutical world when I was going through school and contemplating my future career path. Check out this look at the future of Medical Affair's role in pharma! #pharma #futureofpharma #bridgingthegap #medicalaffairs #professionaldevelopment From inside-out to outside in. ◀️◀️◀️ The strategic shift pharma companies will have to make for medical affairs for the near future: “The shift from historical ‘inside-out’ strategies to broader ‘outside-in’ strategies involves observing and understanding external needs in the wider healthcare ecosystem, incorporating insights from clinicians, researchers, patients, and payers.”

Meet our team of experts, Peter Mondolfi, Senior Director, Business Development and Jason Corder, Associate Director, Business Development, at AAPS 2023 scheduled from 22-25 October, 2023 at Orange County Convention Center, Florida. Visit Booth 3036 to explore our diverse capabilities that helps to accelerate our customers drug product development to ensure speed to market. Aragen offers innovative end-to-end solutions to accelerate clinical candidates through the development cycle. Our scientific team has strong capabilities in solid state, formulation and analytics, guiding difficult to develop drug molecules from preclinical and clinical to market, by resolving solubility, in vivo exposure, solid form and stability issues. We develop a variety of technologies and dosage forms for different routes of administration, in state-of-the-art formulation and analytical laboratories. Working collaboratively with multidisciplinary teams, our drug product experts achieve optimal dosage forms with minimum quantity of drug substance. An experienced technology transfer team ensures developed formulations are manufactured and delivered to support customer clinical studies and data submission for regulatory approval. Write to us at [email protected] to schedule a meeting with our experts at AAPS2023. #AAPS2023 #formulation #preformulation #NCE #genericproduct #drugproduct #clinicalformulation #Aragen #AragenLifeSciences American Association of Pharmaceutical Scientists (AAPS) | @aapscomms

in one place , you will find true , applicable and professional information in your career in pharmaceutical promotion as medical representative or district manager.